C010 Dermatology Review: General
DESCRIPTION
In this session topics of interest to dermatologists will be presented where there have been significant advances or updates. In particular, the evaluation and treatment of bullous diseases, Graft vs host disease, morphea, lupus, dermatomyositis, as is autoimmune blistering diseases, sarcoid, and atopic dermatitis. There are new treatments for atopic dermatitis that will be discussed, including new developments with JAK inhibitors and biologics.
LEARNING OBJECTIVES
Discuss new developments in atopic dermatitis, autoimmune blistering diseases, sarcoidosis patient care.
Discuss the diagnose and treatment options of graft versus host disease.
Discuss evaluation and treatment options of autoimmune skin diseases.
SCHEDULE
9:00 AM
Review of bullous diseases
Mary M Tomayko, MD, PhD, FAAD
9:25 AM
Q&A
9:30 AM
Review of Graft vs Host Disease
Emily Baumrin, MSCE, MD, FAAD
9:55 AM
Q&A
10:00 AM
Update in Morphea/Scleroderma
Nicole Fett, MD, FAAD
10:25 AM
Q&A
10:30 AM
Update in Lupus and Dermatomyositis
Victoria P. Werth, MD, FAAD
10:55 AM
Q&A
11:00 AM
Sarcoidosis
Avrom Caplan, MD, FAAD
11:25 AM
Q&A
11:30 AM
New developments in atopic dermatitis
Eric Lawrence Simpson, MD, FAAD
11:55 AM
Q&A
DIRECTOR
Victoria P. Werth, MD, FAAD
SPEAKERS
Emily Baumrin, MSCE, MD, FAAD
Avrom Caplan, MD, FAAD
Nicole Fett, MD, FAAD
Eric Lawrence Simpson, MD, FAAD
Mary M Tomayko, MD, PhD, FAAD
HANDOUTS
DISCLOSURES
Emily Baumrin, MSCE, MD, FAAD
No financial relationships exist with ineligible companies.
Avrom Caplan, MD, FAAD
Novartis – Consultant (1099 relationship)(Fees); Priovant Therapeutics – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding);
Nicole Fett, MD, FAAD
Astra Zeneca – Investigator(Fees); UpToDate – Other(Honoraria);
Eric Lawrence Simpson, MD, FAAD
AbbVie – Consultant(Fees), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Consultant (1099 relationship)(Fees); Acrotech Biopharma Inc – Investigator(Grants/Research Funding); Almirall – Consultant (1099 relationship)(Fees); Amgen – Consultant(Fees), Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Consultant(Fees); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN – Investigator(Grants/Research Funding); Astria Therapeutics – Consultant (1099 relationship)(Fees); Attovia Therapeutics, Inc – Consultant (1099 relationship)(Fees); Bambusa Therapeutics Inc – Consultant (1099 relationship)(Fees); Castle Biosciences – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); CorEvitas – Consultant(Fees), Investigator(Grants/Research Funding); Demira – Consultant(Fees); Dermavant – Investigator(Grants/Research Funding); Dermira – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Fees), Investigator(Grants/Research Funding); Evomunne – Consultant (1099 relationship)(Fees); FIDE – Speaker/Faculty Education(Fees); Genentech, Inc. – Consultant (1099 relationship)(Fees); Impetus Healthcare – Consultant (1099 relationship)(Fees); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); Infinimmune – Advisory Board(Fees); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Innovaderm Research Inc. – Consultant (1099 relationship)(Fees); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Fees); Kha Khanda UK Employco LTD – Consultant (1099 relationship)(Fees); Kymera Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); La Fonderie Ressources – Consultant (1099 relationship)(Fees); Leo Pharma Inc. – Consultant(Fees); National Jewish Health – Investigator(Grants/Research Funding); Nektar Therapeutics – Consultant (1099 relationship)(Fees); NUMAB Therapeutics AG – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Fees), Investigator(Grants/Research Funding); Recludix Pharma – Consultant (1099 relationship)(Fees); Regeneron – Consultant(Fees), Investigator(Grants/Research Funding); Roche Products Ltd – Consultant (1099 relationship)(Fees); Sanofi – Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Fees), Investigator(Grants/Research Funding); SITRYX – Consultant (1099 relationship)(Fees); Target RWE – Investigator(Grants/Research Funding); UCB – Consultant (1099 relationship)(Fees); Veriskin – Investigator(Grants/Research Funding);
Mary M Tomayko, MD, PhD, FAAD
Astra Zeneca – Advisory Board(Honoraria); Cabaletta Bio – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Otsuka Pharmaceutical Co., Ltd. – Consultant (1099 relationship)(Honoraria);
Victoria P. Werth, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees); Almirall – Consultant (1099 relationship)(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); Architect Therapeutics – Consultant (1099 relationship)(Fees); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Arionix – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Celexor Bio – Consultant (1099 relationship)(Fees); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); Daiichi Sanko – Consultant (1099 relationship)(Honoraria); Dianthus Therapeutics – Consultant (1099 relationship)(Honoraria); Duality Bio – Consultant (1099 relationship)(Fees); EMD Serono – Consultant(Honoraria), Investigator(Grants/Research Funding); First Tracks Biotherapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Glycoera – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Innovaderm Research Inc. – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Odyssey Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Prolium – Consultant (1099 relationship)(Honoraria); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sanofi Aventis – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); Valuence – Consultant (1099 relationship)(Honoraria); Vindico Medical Education – Speaker/Faculty Education(Honoraria);